
Patrick M. Buechner
Examiner (ID: 14872, Phone: (571)270-5171 , Office: P/3754 )
| Most Active Art Unit | 3754 |
| Art Unit(s) | 3799, 3754, OPQA |
| Total Applications | 1001 |
| Issued Applications | 780 |
| Pending Applications | 36 |
| Abandoned Applications | 187 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19112704
[patent_doc_number] => 20240124454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => TRICYCLIC COMPOUND AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/260004
[patent_app_country] => US
[patent_app_date] => 2021-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53009
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18260004
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/260004 | TRICYCLIC COMPOUND AND USE THEREOF | Dec 29, 2021 | Pending |
Array
(
[id] => 17611409
[patent_doc_number] => 20220153688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => HYDRAZONE AMIDE DERIVATIVES AND USE THEREOF IN PREPARATION OF ANTI-OSTEOPOROSIS DRUGS
[patent_app_type] => utility
[patent_app_number] => 17/562040
[patent_app_country] => US
[patent_app_date] => 2021-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9747
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 242
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17562040
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/562040 | Hydrazone amide derivatives and use thereof in preparation of anti-osteoporosis drugs | Dec 26, 2021 | Issued |
Array
(
[id] => 19019293
[patent_doc_number] => 20240075464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => CATALYST FOR GAS-PHASE CATALYTIC AMMOXIDATION REACTION AND METHOD FOR PRODUCING CATALYST FOR GAS-PHASE CATALYTIC AMMOXIDATION REACTION
[patent_app_type] => utility
[patent_app_number] => 18/269890
[patent_app_country] => US
[patent_app_date] => 2021-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16813
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18269890
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/269890 | CATALYST FOR GAS-PHASE CATALYTIC AMMOXIDATION REACTION AND METHOD FOR PRODUCING CATALYST FOR GAS-PHASE CATALYTIC AMMOXIDATION REACTION | Dec 23, 2021 | Pending |
Array
(
[id] => 19083116
[patent_doc_number] => 20240109917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/258675
[patent_app_country] => US
[patent_app_date] => 2021-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 156746
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18258675
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/258675 | PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS | Dec 21, 2021 | Pending |
Array
(
[id] => 17533558
[patent_doc_number] => 20220112167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => Method For Preparing Aryl 2-Tetrazol-1-Yl Keto With Improved Selectivity
[patent_app_type] => utility
[patent_app_number] => 17/555801
[patent_app_country] => US
[patent_app_date] => 2021-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4775
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17555801
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/555801 | Method For Preparing Aryl 2-Tetrazol-1-Yl Keto With Improved Selectivity | Dec 19, 2021 | Abandoned |
Array
(
[id] => 18987684
[patent_doc_number] => 20240059653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => METHOD OF SYNTHESIZING INDOLE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/259578
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26508
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -83
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18259578
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/259578 | Method of synthesizing indole compounds | Dec 16, 2021 | Issued |
Array
(
[id] => 18879035
[patent_doc_number] => 20240002404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => SALT OF PYRROLOPYRIMIDINE COMPOUND, CRYSTALLINE FORM THEREOF, AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/254186
[patent_app_country] => US
[patent_app_date] => 2021-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14721
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18254186
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/254186 | SALT OF PYRROLOPYRIMIDINE COMPOUND, CRYSTALLINE FORM THEREOF, AND APPLICATION THEREOF | Dec 5, 2021 | Pending |
| 17/616921 | TETRA-FUNCTIONAL CHEMICAL PROBE AND METHOD FOR IDENTIFYING TARGET MEMBRANE PROTEIN FROM LIVING CELL OR LIVING TISSUE BY USING SAID PROBE | Dec 5, 2021 | Pending |
Array
(
[id] => 17627212
[patent_doc_number] => 20220162227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => METHODS FOR THE PREPARATION OF 1,3-BENZODIOXOLE HETEROCYCLIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/539715
[patent_app_country] => US
[patent_app_date] => 2021-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9188
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17539715
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/539715 | Methods for the preparation of 1,3-benzodioxole heterocyclic compounds | Nov 30, 2021 | Issued |
Array
(
[id] => 17807319
[patent_doc_number] => 20220259154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR
[patent_app_type] => utility
[patent_app_number] => 17/539679
[patent_app_country] => US
[patent_app_date] => 2021-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50764
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17539679
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/539679 | Compounds and methods for the targeted degradation of androgen receptor | Nov 30, 2021 | Issued |
Array
(
[id] => 17929695
[patent_doc_number] => 20220324820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => METHODS AND COMPOSITIONS FOR GAMMA-GLUTAMYL CYCLE MODULATION
[patent_app_type] => utility
[patent_app_number] => 17/537266
[patent_app_country] => US
[patent_app_date] => 2021-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21482
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17537266
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/537266 | METHODS AND COMPOSITIONS FOR GAMMA-GLUTAMYL CYCLE MODULATION | Nov 28, 2021 | Pending |
Array
(
[id] => 18853879
[patent_doc_number] => 11851440
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-26
[patent_title] => Modulators of eukaryotic initiation factor 2B, compositions and methods
[patent_app_type] => utility
[patent_app_number] => 17/531039
[patent_app_country] => US
[patent_app_date] => 2021-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55266
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17531039
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/531039 | Modulators of eukaryotic initiation factor 2B, compositions and methods | Nov 18, 2021 | Issued |
Array
(
[id] => 18153041
[patent_doc_number] => 11566001
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-31
[patent_title] => Hepatitis B capsid assembly modulators
[patent_app_type] => utility
[patent_app_number] => 17/514578
[patent_app_country] => US
[patent_app_date] => 2021-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38757
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17514578
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/514578 | Hepatitis B capsid assembly modulators | Oct 28, 2021 | Issued |
Array
(
[id] => 19717279
[patent_doc_number] => 12202802
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-21
[patent_title] => Styryl quinolinium, process for their preparation and use thereof as fluorescent probes for imaging
[patent_app_type] => utility
[patent_app_number] => 17/507028
[patent_app_country] => US
[patent_app_date] => 2021-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 16
[patent_no_of_words] => 6222
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17507028
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/507028 | Styryl quinolinium, process for their preparation and use thereof as fluorescent probes for imaging | Oct 20, 2021 | Issued |
Array
(
[id] => 17385501
[patent_doc_number] => 20220033353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => PROCESS FOR PREPARING CYANOACETATES
[patent_app_type] => utility
[patent_app_number] => 17/503914
[patent_app_country] => US
[patent_app_date] => 2021-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1487
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17503914
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/503914 | Process for preparing cyanoacetates | Oct 17, 2021 | Issued |
Array
(
[id] => 17385498
[patent_doc_number] => 20220033350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => PROCESS FOR PREPARING CYANOACETATES
[patent_app_type] => utility
[patent_app_number] => 17/503897
[patent_app_country] => US
[patent_app_date] => 2021-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1884
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17503897
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/503897 | Process for preparing cyanoacetates | Oct 17, 2021 | Issued |
Array
(
[id] => 18986486
[patent_doc_number] => 20240058455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => BIOORTHOGONAL LINKERS AND REACTIONS
[patent_app_type] => utility
[patent_app_number] => 18/247571
[patent_app_country] => US
[patent_app_date] => 2021-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46359
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -59
[patent_words_short_claim] => 189
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18247571
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/247571 | BIOORTHOGONAL LINKERS AND REACTIONS | Oct 3, 2021 | Pending |
Array
(
[id] => 17561618
[patent_doc_number] => 20220125767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => THIAZOLIDE COMPOUNDS FOR TREATING VIRAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/491878
[patent_app_country] => US
[patent_app_date] => 2021-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9977
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17491878
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/491878 | THIAZOLIDE COMPOUNDS FOR TREATING VIRAL INFECTIONS | Sep 30, 2021 | Abandoned |
Array
(
[id] => 19343525
[patent_doc_number] => 20240252488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => MLKL BINDING OR DEGRADING COMPOUND AND PHARMACEUTICAL USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/246773
[patent_app_country] => US
[patent_app_date] => 2021-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 88880
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 287
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18246773
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/246773 | MLKL BINDING OR DEGRADING COMPOUND AND PHARMACEUTICAL USE THEREOF | Sep 26, 2021 | Pending |
Array
(
[id] => 19083052
[patent_doc_number] => 20240109853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => ALPHA PROTEIN KINASE 1 INHIBITORS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/246586
[patent_app_country] => US
[patent_app_date] => 2021-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48511
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18246586
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/246586 | ALPHA PROTEIN KINASE 1 INHIBITORS AND METHODS OF USE | Sep 22, 2021 | Pending |